News
Double the number of patients at half the cost: digital innovation in Mohs surgery
The worldwide increase in cancer, predicted by the International Agency for Research on Cancer (IARC), requires the urgent optimisation and digitalisation of current treatment processes. A pioneering study led by Prof. Dr Jan Gutermuth at the University Hospital of Brussels presents a revolutionary approach: the integration of Ex Vivo Confocal Microscopy (EVCM) during Mohs Micrographic Surgery (MMS) for Basal Cell Carcinoma (BCC) using the VivaScope 2500, which has been proven to enable a more precise and faster assessment of tumour extension and resection margins, leading to a significant increase in efficiency. Prof Dr Jan Gutermuth and his team have proven that the waiting time for patients has been reduced, costs have been more than halved and the quality of patient care has been improved. The results have far-reaching implications for the healthcare system by enabling more effective and cost-efficient treatment of skin cancer.